跳转至内容
Merck
CN

P1152

聚(Ala, Glu, Lys, Tyr) 6:2:5:1 氢溴酸盐

greener alternative

Ala:Glu:Lys:Tyr (6:2:5:1), mol wt 20,000-30,000

别名:

(L-Ala, L-Glu, L-Lys, L-Tyr)n ·HBr, COP-1

登录 查看组织和合同定价。

选择尺寸

关于此项目

化学文摘社编号:
28704-27-0
UNSPSC Code:
12352202
NACRES:
NA.26
MDL number:
MFCD00166401

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

聚(Ala, Glu, Lys, Tyr) 6:2:5:1 氢溴酸盐, Ala:Glu:Lys:Tyr (6:2:5:1), mol wt 20,000-30,000

SMILES string

N[C@@H](CCCCN)C(=O)O.N[C@@H](Cc1ccc(cc1)O)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](C)C(=O)O

InChI

1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1-2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6)/t8-;5-;3-;2-/m0000/s1

InChI key

YLOCGHYTXIINAI-XKUOMLDTSA-N

form

powder

feed ratio

Ala:Glu:Lys:Tyr (6:2:5:1)

mol wt

20,000-30,000

greener alternative product score

old score: 56
new score: 39
Find out more about DOZN™ Scoring

greener alternative product characteristics

Designing Safer Chemicals
Safer Solvents and Auxiliaries
Reduce Derivatives
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

color

white to off-white

greener alternative category

, Re-engineered

storage temp.

−20°C

Quality Level

200

相关类别

Analysis Note

基于粘度报告的分子量。

Biochem/physiol Actions

聚（Ala，Glu，Lys，Tyr）6:2:5:1氢溴酸盐是一种聚氨基酸，据报道对过敏性脑脊髓炎具有抑制作用。
据报道对实验动物诱发的实验性变态反应性脑脊髓炎有抑制作用。

General description

我们竭诚为您带来满足绿色替代产品四大类别要求的替代产品。本品属于重新设计产品类别，在“设计更安全的化学品”、“更安全的溶剂和助剂”以及“减少衍生物”绿色化学原则方面取得了重大进步。 点击此处查看其 DOZN 记分卡。

Other Notes

有关聚氨基酸的其他技术信息，请访问 聚氨基酸常见问题解答资源。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000331726
0000331726
0000276030
0000276030
SLBH2744V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Dominant epitopes and synthetic peptides in myasthenia gravis.
M Sela et al.
Israel journal of medical sciences, 31(1), 10-12 (1995-01-01)
Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
Y Stark
Annals of neurology, 36(1), 114-115 (1994-07-01)
Carmen C M Chan
Recent patents on CNS drug discovery, 3(3), 189-199 (2008-11-11)
Spinal cord injury leads to a devastating cascade of secondary complications that eventually results in the formation of scar tissue many times the size of the original insult. Inflammation plays a very important role towards the development of such scar
E Zisman et al.
European journal of immunology, 24(10), 2497-2505 (1994-10-01)
Studies with the well-characterized, synthetic, random-multichain polypeptide poly(LTyr,LGlu)-poly(DLAla)-poly(LLys) (T,G)-A-L) led to the discovery of determinant-specific genetic control of the immune response, as well as to other immunological phenomena. Moreover, the tetrapeptide TyrTyrGluGlu built on the same backbone ("(T-T-G-G)-A--L") was found
Byoung-Joo Choi et al.
Japanese heart journal, 45(4), 697-702 (2004-09-09)
A 16 year-old Korean girl with cardiomegaly was found to have a "right atrial cystic mass" on transthoracic echocardiography. An unusual cystic structure made the diagnosis difficult. However, transesophageal echocardiography and multidetector computed tomography revealed a coronary artery fistula with
查看所有相关文献

商品

Poly(Amino Acid) Block Copolymers for Drug Delivery and other Biomedical Applications

Humankind has utilized protein materials throughout its existence, starting with the use of materials such as wool and silk for warmth and protection from the elements and continuing with the use of recombinant DNA techniques to synthesize proteins with unique and useful properties.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持